JORGE E CORTES to Hepatic Veno-Occlusive Disease
This is a "connection" page, showing publications JORGE E CORTES has written about Hepatic Veno-Occlusive Disease.
Connection Strength
0.237
-
Prevention, recognition, and management of adverse events associated with gemtuzumab ozogamicin use in acute myeloid leukemia. J Hematol Oncol. 2020 10 15; 13(1):137.
Score: 0.165
-
Ursodiol does not prevent hepatic venoocclusive disease associated with Mylotarg therapy. Haematologica. 2002 Oct; 87(10):1114-6.
Score: 0.047
-
Intravenous corticosteroids to reduce gemtuzumab ozogamicin infusion reactions. Ann Pharmacother. 2003 Sep; 37(9):1182-5.
Score: 0.013
-
Pilot study of Mylotarg, idarubicin and cytarabine combination regimen in patients with primary resistant or relapsed acute myeloid leukemia. Cancer Chemother Pharmacol. 2003 Jan; 51(1):87-90.
Score: 0.012